Important Information for Human Cell, Tissue, and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Ebola Disease and HCT/P Donation

Summary

FDA issued guidance communication to HCT/P establishments regarding Ebola disease and donor eligibility considerations for human cell, tissue, and cellular/tissue-based products. This is routine regulatory guidance with no material impact on specific drug programs or companies.